Altria

Altria Posts Better-Than-Expected Q3 Results On Robust Demand For Vapes, Nicotine Pouches

Altria Group beats market expectations for third-quarter revenue and profit, as robust demand for its nicotine pouches and e-cigarettes helped soften...

US FDA Rescinds Market Denial Order For Juul Products

The US Food and Drug Administration (FDA) said it was rescinding a June 2022 order that briefly blocked sale of Juul's products, including its device for e...

Altria Tops Q1 Sales On Higher Pricing, Robust Demand For Smokeless Alternatives

Altria Group topped quarterly sales expectations, driven by higher pricing and rising demand for alternatives to conventional tobacco products.

Brewer AB InBev's Shares Slip On Altria's Stake Sale

Anheuser-Busch InBev's shares fell over 4% after a trading suspension was lifted following more details on tobacco giant Altria's stake sale in the brewer.

BAT Shores Up US Heated Tobacco Prospects As Competition Grows

British American Tobacco has submitted an application to market its Glo Hyper device as a reduced-risk product in the United States, its first movement in...

Altria Edges Past Quarterly Profit Expectations On Higher Pricing

Marlboro maker Altria edged past fourth-quarter adjusted profit expectations, as higher prices and a shift to alternative nicotine products helpe...

Marlboro Maker Cuts Profit Forecast As Smokers Swap To Cheaper Brands

Tobacco giant Altria Group cut its annual profit forecast as more smokers swapped its higher priced cigarettes for cheaper brands or smoking alternatives.